open-angle glaucoma and ocular hypertension
Ophthalmology · 2005–2022
15decisions
8medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| dorzolamide with timolol Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate. | Mar 2022 | Recommended | unclear |
| brinzolamide / brimonidine tartrate Treatment of elevated intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension whose condition is inadequately controlled with… | Jul 2015 | Recommended with restriction | none received |
| betaxolol, bimatoprost, bimatoprost + timolol, brimonidine, brimonidine + timolol, brinzolamide, brinzolamide + timolol, dorzolamide, dorzolamide + timolol, latanoprost, latanoprost + timolol, pilocarpine, timolol, travoprost, timolol + travoprost Treatment of elevated intra-ocular pressure in glaucoma and ocular hypertension, prescribed by optometrists in accordance with Optometry Board of Australia… | Mar 2015 | Recommended with restriction | input received |
| dorzolamide hydrochloride with timolol maleate Reduction of elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension that is not adequately controlled with monotherapy. | Jul 2012 | Recommended with restriction | no section in document |
| dorzolamide hydrochloride with timolol maleate Reduction of elevated intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension that is not adequately controlled with monotherapy. | Jul 2012 | Recommended with restriction | no section in document |
| brinzolamide with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are not adequately controlled with timolol… | Mar 2010 | Recommended with restriction | no section in document |
| brinzolamide with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension not adequately controlled with monotherapy. | Mar 2010 | Recommended with restriction | no section in document |
| bimatoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are not adequately controlled with timolol maleate… | Mar 2009 | Recommended with restriction | no section in document |
| travoprost with timolol maleate Reduction of elevated intra-ocular pressure in patients with open angle glaucoma or ocular hypertension who are not adequately controlled with beta-blockers or… | Mar 2007 | Recommended with restriction | no section in document |
| travoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient… | Jul 2006 | Recommended with restriction | no section in document |
| latanoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are not adequately controlled with timolol… | Jul 2005 | Deferred | no section in document |
| latanoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are not adequately controlled with timolol maleate… | Nov 2005 | Recommended with restriction | no section in document |
| travoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom a single agent therapy provides insufficient… | Nov 2005 | Recommended | no section in document |
| latanoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are not adequately controlled with timolol maleate… | Nov 2005 | Recommended with restriction | no section in document |
| travoprost with timolol maleate Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom a single agent therapy provides insufficient… | Nov 2005 | Recommended | no section in document |
What the PBS pays
$397M in government benefit over 2024–25, across 19,364,483 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| Betaxolol, Bimatoprost, Bimatoprost + Timolol, Brimonidine, Brimonidine + Timolol, Brinzolamide, Brinzolamide + Timolol, Dorzolamide, Dorzolamide + Timolol, Latanoprost, Latanoprost + Timolol, Pilocarpine, Timolol, Travoprost, Timolol + Travoprost | $69.6M |
| latanoprost with timolol maleate | $48.5M |
| brinzolamide with timolol maleate | $44M |
| bimatoprost with timolol maleate | $40.1M |
| travoprost with timolol maleate, eye drops | $37.2M |
| travoprost with timolol maleate | $37.2M |
| dorzolamide hydrochloride with timolol maleate, eye drops | $34.7M |
| dorzolamide hydrochloride with timolol maleate | $34.7M |
| dorzolamide with timolol | $34.7M |
| brinzolamide/brimonidine tartrate | $16.2M |
Appraised elsewhere
NICE, in England and Wales, has appraised 1 technology for this condition, recommending 0 . A different committee, a different population and a different price: this is what has been looked at there, not a verdict on what happened here.
| Technology | Appraisal | Outcome | Date |
|---|---|---|---|
| netarsudilNetarsudil for treating open-angle glaucoma or ocular hypertension (terminated evaluation) | TA1180 | terminated | 2026-07 |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.